# Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)

> **NCT03876158** · PHASE4 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Chronic Pain
- Intractable Pain
- Back Pain

## Interventions

- **DEVICE:** Prometra II Programmable Pump system(Flowonix Medical)

## Key facts

- **NCT ID:** NCT03876158
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2022-03
- **Final completion:** 2022-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study will not be conducted by Dr Lubenow
- **Last updated:** 2020-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876158, "Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03876158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*